Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amlodipine/Valsartan vs Hydrochlorothiazide/Telmisartan for Glucose Tolerance in Hypertension
NCT01819220Phase 4Completed
- Sponsor
- Yonsei University
- Start
- Apr 2009
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of amlodipine and valsartan in hypertension (HTN) (2 arms), sponsored by Yonsei University. Primary endpoint: 2-hour post-prandial plasma glucose level at 24 weeks. Started Apr 2009; status: completed.
02
Drugs
amlodipinevalsartan
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT01819220.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01819220.